Stanley B Cohen (Stanley Cohen)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 15

Top Topics

Rheumatoid Arthritis

Atopic Dermatitis

Top Venues

Rheumatology and therapy

Arthritis & rheumatology (Hoboken, N.J.)

Clinical rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Matthew C Baker, Sarah Kavanagh, Stanley B Cohen, Alan K Matsumoto, Ara Dikranian, John Tesser, Alan Kivitz, Konstantinos Alataris, Mark C Genovese
A Randomized, Double-Blind, Sham-Controlled, Clinical Trial of Auricular Vagus Nerve Stimulation for the Treatment of Active Rheumatoid Arthritis. Arthritis & rheumatology (Hoboken, N.J.) (2023)
Gerd-Rüdiger R Burmester, Stanley B Cohen, Kevin L Winthrop, Peter Nash, Alan D Irvine, Atul Deodhar, Eduardo Mysler, Yoshiya Tanaka, John Liu, Ana P Lacerda, Hannah Palac, Tim Shaw, Phillip J Mease, Emma Guttman-Yassky
Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis. RMD open 9 (1) (2023)
Gerd-Rüdiger R Burmester, Stanley B Cohen, Kevin L Winthrop, Peter Nash, Alan D Irvine, Atul Deodhar, Eduardo Mysler, Yoshiya Tanaka, John Liu, Ana P Lacerda, Hannah Palac, Tim Shaw, Phillip J Mease, Emma Guttman-Yassky
Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis. RMD open 9 (1) (2023)
Gerd-Rüdiger R Burmester, Stanley B Cohen, Kevin L Winthrop, Peter Nash, Alan D Irvine, Atul Deodhar, Eduardo Mysler, Yoshiya Tanaka, John Liu, Ana P Lacerda, Hannah Palac, Tim Shaw, Phillip J Mease, Emma Guttman-Yassky
Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis. RMD open 9 (1) (2023)
Gerd-Rüdiger R Burmester, Stanley B Cohen, Kevin L Winthrop, Peter Nash, Alan D Irvine, Atul Deodhar, Eduardo Mysler, Yoshiya Tanaka, John Liu, Ana P Lacerda, Hannah Palac, Tim Shaw, Phillip J Mease, Emma Guttman-Yassky
Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis. RMD open 9 (1) (2023)
Gerd-Rüdiger R Burmester, Stanley B Cohen, Kevin L Winthrop, Peter Nash, Alan D Irvine, Atul Deodhar, Eduardo Mysler, Yoshiya Tanaka, John Liu, Ana P Lacerda, Hannah Palac, Tim Shaw, Phillip J Mease, Emma Guttman-Yassky
Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis. RMD open 9 (1) (2023)
Kevin L Winthrop, Arne Yndestad, Dan Henrohn, Silvio Danese, Sara Marsal-Barril, Maria Galindo, John C Woolcott, Hyejin Jo, Kenneth Kwok, Andrea B Shapiro, Thomas V Jones, Annette Diehl, Chinyu Su, Julian Panes, Stanley B Cohen
Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs. Rheumatology and therapy (2022)
Kevin L Winthrop, Arne Yndestad, Dan Henrohn, Silvio Danese, Sara Marsal-Barril, Maria Galindo, John C Woolcott, Hyejin Jo, Kenneth Kwok, Andrea B Shapiro, Thomas V Jones, Annette Diehl, Chinyu Su, Julian Panes, Stanley B Cohen
Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs. Rheumatology and therapy 10 (2) (2022)
Kevin L Winthrop, Arne Yndestad, Dan Henrohn, Silvio Danese, Sara Marsal-Barril, Maria Galindo, John C Woolcott, Hyejin Jo, Kenneth Kwok, Andrea B Shapiro, Thomas V Jones, Annette Diehl, Chinyu Su, Julian Panes, Stanley B Cohen
Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs. Rheumatology and therapy (2022)
Kevin L Winthrop, Arne Yndestad, Dan Henrohn, Silvio Danese, Sara Marsal-Barril, Maria Galindo, John C Woolcott, Hyejin Jo, Kenneth Kwok, Andrea B Shapiro, Thomas V Jones, Annette Diehl, Chinyu Su, Julian Panes, Stanley B Cohen
Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs. Rheumatology and therapy 10 (2) (2022)
Stanley B Cohen, Theodore Mellors, Martin J Bergman
Use of Precision Medicine to Guide Treatment of Patients With Rheumatoid Arthritis: Comment on the Article by Tao et al. Arthritis & rheumatology (Hoboken, N.J.) 73 (8) (2021)
Philip Gerard Conaghan, Eduardo Mysler, Yoshiya Tanaka, Barbara Da Silva-Tillmann, Tim Shaw, John Liu, Ryan Ferguson, Jeffrey V Enejosa, Stanley B Cohen, Peter Nash, William F C Rigby, Gerd-Rüdiger R Burmester
Upadacitinib in Rheumatoid Arthritis: A Benefit-Risk Assessment Across a Phase III Program. Drug safety 44 (5) (2021)
Stanley B Cohen, Katie Tuckwell, Tamiko R Katsumoto, Rui Zhao, Joshua Galanter, Chin Lee, Julie Rae, Balazs Toth, Nandhini Ramamoorthi, Jason A Hackney, Alberto Berman, Nemanja Damjanov, Dmytro Fedkov, Slawomir Jeka, Leslie W Chinn, Michael J Townsend, Alyssa M Morimoto, Mark C Genovese
Fenebrutinib versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double-Blind, Phase II Trial (ANDES Study). Arthritis & rheumatology (Hoboken, N.J.) (2020)
Stanley B Cohen, Ahmed Samad, Elaine Karis, Bradley S Stolshek, Mona Trivedi, Hao Zhang, Girish A Aras, Greg Kricorian, James B Chung
Decreased Injection Site Pain Associated with Phosphate-Free Etanercept Formulation in Rheumatoid Arthritis or Psoriatic Arthritis Patients: A Randomized Controlled Trial. Rheumatology and therapy 6 (2) (2019)
Stanley B Cohen, Joel M Kremer, Kimberly J Dandreo, George W Reed, Robert Magner, Ying Shan, Shelly Kafka, Raphael J DeHoratius, Lorie Ellis, Dennis Parenti
Outcomes of infliximab dose escalation in patients with rheumatoid arthritis. Clinical rheumatology 38 (9) (2019)